A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia.

Sandhöfer, Nadine; Metzeler, Klaus H; Kakadia, Purvi M; Pasalic, Zlatana; Hiddemann, Wolfgang; Neusser, Michaela; Steinlein, Ortrud; Fiegl, Michael; Subklewe, Marion; Spiekermann, Karsten; Bohlander, Stefan K; Schneider, Stephanie; Braess, Jan

Sandhöfer, Nadine; Metzeler, Klaus H; Kakadia, Purvi M; Pasalic, Zlatana; Hiddemann, Wolfgang; Neusser, Michaela; Steinlein, Ortrud; Fiegl, Michael; Subklewe, Marion; Spiekermann, Karsten; Bohlander, Stefan K; Schneider, Stephanie; Braess, Jan.

Afiliação

Sandhöfer N; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Metzeler KH; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Kakadia PM; Department of Molecular Medicine and Pathology, University of Auckland, New Zealand.
Pasalic Z; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Hiddemann W; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Neusser M; Institute of Human Genetics, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Steinlein O; Institute of Human Genetics, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Fiegl M; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Subklewe M; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Spiekermann K; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, New Zealand.
Schneider S; Department of Internal Medicine III, Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University, Munich, Germany.
Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.

Genes Chromosomes Cancer ; 56(8): 632-638, 2017 08.

Article em En | MEDLINE | ID: mdl-28420034

Assuntos

Aberrações Cromossômicas; Análise Citogenética/métodos; Leucemia Promielocítica Aguda/genética; Adulto; Idoso; Idoso de 80 Anos ou mais; Feminino; Humanos; Hibridização in Situ Fluorescente/métodos; Cariótipo; Leucemia Promielocítica Aguda/diagnóstico; Masculino; Pessoa de Meia-Idade; Sensibilidade e Especificidade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Aberrações Cromossômicas / Análise Citogenética Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google